APA aipamena

Buckley, N. E., Forde, C., McArt, D. G., Boyle, D. P., Mullan, P. B., James, J. A., . . . Salto-Tellez, M. (2016). Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment. Sci Rep.

Chicago Style aipamena

Buckley, Niamh E., Claire Forde, Darragh G. McArt, David P. Boyle, Paul B. Mullan, Jacqueline A. James, Perry Maxwell, Stephen McQuaid, and Manuel Salto-Tellez. "Quantification of HER2 Heterogeneity in Breast Cancer–implications for Identification of Sub-dominant Clones for Personalised Treatment." Sci Rep 2016.

MLA aipamena

Buckley, Niamh E., et al. "Quantification of HER2 Heterogeneity in Breast Cancer–implications for Identification of Sub-dominant Clones for Personalised Treatment." Sci Rep 2016.